Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Glucotrack, Inc. Director's Dealing 2025

Mar 29, 2025

35378_dirs_2025-03-28_9abae59f-6246-408d-8ef6-4902b2c4adc7.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Glucotrack, Inc. (GCTK)
CIK: 0001506983
Period of Report: 2025-03-26

Reporting Person: Balo Andrew K (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-03-26 Common Stock, par value $0.001 per share A 4490 Acquired 4490 Direct